Amendment and Correction in DG-ESIC Rate Contract 165 to 169
ESIC circular U-25/12/165to169/2024-MedicalV · 23 Apr 2026
Official title
Amendment and Correction in r/o DG-ESIC Rate Contract No. 165 to 169-reg. (English)
Official record
Open source pageSummary
Check the official recordWhat changed
The Employees' State Insurance Corporation amends and corrects details for DG-ESIC Rate Contract numbers 165 to 169. The amendment changes the packing size for Lactulose Syrup, item number 478 under RC 165, from 200ml bottle to 100ml bottle for Wings Biotech LLP. The correction updates the name of the approved pharmaceutical firm for Paracetamol Injection, item number 1541 under RC 165, from J. B. Chemicals Pvt. Ltd. to JB Chemicals & Pharmaceuticals Ltd. All other terms and conditions of the original rate contracts remain unchanged. This document serves as an integral part of the original rate contract documents.
What you must do
- Consider the amendment and correction in the DG-ESIC Rate Contract Nos. 165 to 169.
Key dates
- Date of issuance
- 22 Apr 2026
Who is affected
Document text
U-25/12/165to169/2024-MedicalV कर्मचारी राज्य बीमा निगम (श्रम एवं रोजगार मंत्रालय, भारत सरकार) EMPLOYEES' STATE INSURANCE CORPORATION (Ministry of Labour & Employment, Govt. of India) मुख्यालय/ HEADQUARTERS पंचदीप भवन, सी.आई.जी मार्ग, नई दिल्ली -110002 Panchdeep Bhawan,CI.G. Marg, New Dethi-110002 www.esic.rov.in, 011-23604773 gms-rc@esic.nicin No.:U-25/12/165to169/2024-MedicalV (E-754406) To, 1144 Date: 22-04-2026 Director (Medical) Delhi/Director (Medical) Noida Deans- AlI PGIMSR's/Medical/Dental Colleges Medical Superintendents-All ESI Hospitals Dispensary In charges- Delhi/NCR/States Directors ESI Schemes- All State Amendment/ Correction -DG-ESIC RC 165 to 169 Subject: Amendment and Correction in r/o DG-ESIC Rate Contract No. 165 to 169- reg. Reference: 1.) U-25/12/165 to 169/2024-Medical.V (E-754406)/165,166,167,168 & 169 dated 12.12.2025 uploaded on ESIC Hqrs website vide console no. 23712/2025 on 12.12.2025. 2.) U-25/12/165 to 169/2024-Medical.V (E-754406)/81 dtd 10.03.2026 uploaded on ESIC Hqrs website vide console no. 24701/2026 on 11.03.2026. Sir/Madam, With reference to the captioned subject and in continuation of ESIC Headquarters circulars of even number dated 12.12.2025 and 11.03.2026, uploaded on the ESIC Headquarters website vide above-mentioned console numbers, it is hereby informed that the following amendment (Table-A) and correction (Table-B) are to be considered in the DG-ESIC Rate Contract Nos. 165 to 169, as detailed below:
Table-A: Amendment
| RC No. | RC Item No. | Approved Pharmaceutical Firm | Item Name and Description | Existing "Packing Offered by firm" | Amended "Packing Offered by firm" |
|---|---|---|---|---|---|
| 165 | 478 | Wings Biotech LLP | Lactulose Syp- Each 15 ml to contain Lactulose 10gm., Packing- 100ml to 150ml Bottle | 200ml Bottle | 100 ml Bottle |
Table-B: Correction
| RC No. | RC Item No. | Item Name and Description | Existing name of "Approved Pharmaceutical Firm" | Corrected name of "Approved Pharmaceutical Firm" |
|---|---|---|---|---|
| 165 | 1541 | Paracetamol Inj - Each ml to contain: Paracetamol 10 mg,100ml Bottle | J. B. Chemicals Pvt. Ltd. | JB Chemicals & Pharmaceuticals Ltd |
1/3836861/2026
U-25/12/165to169/2024-MedicalV All other contents & Terms and Condition of the DG-ESIC Rate Contract 165 to 169 will remain the same. This corrigendum shall be considered an integral part of the original documents. This is for information and kind consideration please. This issued with the approval of Competent Authority. Enclosures: As above Copy to: Yours faithfully Digitally signed by Sanjiv Kochhar Date: 22-04-2026 20:26:13 Dy. Medical Commissioner (RC/PC)
- M/s Wings Biotech LLP J-13, Udyog Nagar Industrial Area, Near Peeragarhi Metro Station, Delhi- 110041 (Email- manager.govtsupply@wingsbiotech.com,institution.exe@wingsbiotech.com, wingster [unclear in source] for kind information and strictly compliance please.
- M/s J. B. Chemicals Pvt. Ltd., Neelam Centre, B Wing, 4th floor, Hind Cycle Road, Worli, Mumbai:400030 (Email- sajida.khan@jbpharma.com,anand.prasad@jbpharma.com) for kind information please
- Website Content Manager for uploading on ESIC HQRS Website.
- Guard File. 1/3836861/2026
Source details
- Source
- Employees' State Insurance Corporation
- Type
- circular
- Published by source
- 23 Apr 2026
- Document number
- U-25/12/165to169/2024-MedicalV
- Coverage area
- labour